“pfizer” Archives

in
Entry Author Date Location
Healthcare + A.I. in Boston: The Photos 11/16/17 Boston
FDA Lifts Hold on Cellectis’s “Off the Shelf” CAR-T, With Caveats 11/07/17 New York
Xconomy Newcomer Award Winner Amy Schulman on Boston Biotech Life 11/06/17 Boston
AgTech Accelerator Brings Biopharma Models to Ag Investing Strategy 11/06/17 Raleigh Durham
Announcing New York Biotech: The Future is Now on Dec. 11 10/24/17 National
Healthcare + A.I. at Pfizer on Nov. 2: Here’s the Agenda 10/13/17 Boston
Merck Abandons Plans to Seek FDA Approval of Cholesterol Drug 10/11/17 New York
Eli Lilly Drug Fails in Lung Cancer, Stalling Oncology Strategy 10/10/17 Indiana
Bio Roundup: Graham-Cassidy, Axovant Fail, SpringWorks Launches & More 09/29/17 National
Deciphera IPO Drums Up $128M for Cancer Drug Studies 09/28/17 Boston
SpringWorks Spins Out of Pfizer With $103M to Give Shelved Drugs New Life 09/25/17 New York
Pfizer, Veritas, MGH Join Xconomy’s Healthcare + A.I. Conference on Nov. 2 09/22/17 Boston
Last Chance to Save on Boston’s Life Science Disruptors 09/20/17 Boston
Alnylam Data Puts a Nobel Discovery One Step Closer to Approved Drug 09/20/17 Boston
Halozyme Inks $105M Bristol-Myers Partnership, Expands Roche Deal 09/14/17 San Diego
23andMe Raises $250M For Consumer Disease-Risk Tests, Drug R&D 09/12/17 San Francisco
Seeking to Cash in For Investors Again, Rhythm Pharma Files For IPO 09/06/17 Boston
Patient Death Triggers FDA Hold For Cellectis’s “Off the Shelf” CAR-T 09/05/17 New York
Jazz Pharma, ImmunoGen Strike Up Drug Pact in Leukemia and More 08/29/17 Boston
Will Merck Seek FDA Filing For Heart Drug After Lackluster Results? 08/29/17 New York
WARF’s Erik Iverson Announces New VC Funds, Therapeutics Program 08/23/17 Wisconsin
Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More 08/11/17 National
Dragonfly, Tyler Jacks Sign On for Boston’s Life Science Disruptors on Sept. 28 08/09/17 Boston
New Rapamycin CEO Hired to Handle Funding, FDA Inflection Points 08/07/17 Texas
Check Out Tesaro & More at “Disruptors” on Sept. 28; Super Saver Rate Ends Today 08/03/17 Boston
San Antonio Biomedical Group Awards Miami Healthcare Researcher 08/02/17 Texas
With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug 08/01/17 Boston
Five Questions For … Houston Medical Device Investor Larry Lawson 06/23/17 Texas
Rubius Adds $120M to Ready Tests of Red Blood Cells as Drug Carriers 06/21/17 Boston
Checkmate Pharma Clinches $27M for More Studies in Skin Cancer 06/15/17 Boston
Page 1 of 26 next page »